Dell Children's Medical Center
Welcome,         Profile    Billing    Logout  
 10 Trials 
45 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chang, Alicia Hsin-Ming
NCT06579703: Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease

Not yet recruiting
4
102
NA
Ketorolac, Toradol
Children's Blood and Cancer Center at Dell Children's Medical Center
Sickle Cell Disease, Sickle Cell Crisis, Veno-occlusive Disease
07/27
02/28
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Recruiting
N/A
1000
US
Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®
Pfizer, Pfizer
Sickle Cell Disease
01/30
01/30
Stromberg, Daniel
pediRES-Q, NCT02708134: Quality of Pediatric Resuscitation in a Multicenter Collaborative

Recruiting
N/A
5000
Europe, Canada, Japan, US, RoW
Children's Hospital of Philadelphia, Zoll Medical Corporation
Cardiac Arrest, Cardiopulmonary Arrest
01/28
01/30
Berry-Kravis, Elizabeth
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Recruiting
3
150
US
BPN14770/ zatolmilast, Placebo
Tetra Discovery Partners
Fragile X Syndrome
06/25
09/25
NCT05367960: An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Enrolling by invitation
3
300
US
Zatolmilast/ BPN14770
Tetra Discovery Partners
Fragile X Syndrome
09/27
12/27
RECONNECT, NCT04977986: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults with Fragile X Syndrome

Recruiting
3
250
Europe, US, RoW
ZYN002 - transdermal gel, cannabidiol formulated as a clear gel that can be applied to the skin (transdermal delivery), Placebo, Placebo Comparator, Matching Placebo
Zynerba Pharmaceuticals, Inc.
Fragile X Syndrome
05/25
05/25
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Recruiting
2/3
150
US
zatolmilast, BPN14770, Placebo
Tetra Discovery Partners
Fragile X Syndrome
09/25
12/25
NCT05030129: ERG/5-HTP in Fragile X Syndrome (FXS)

Completed
2
15
US
5-Hydroxytryptophan, 5-HTP, Basic Vitamins, Ergoloid Mesylates, Medisca, Matching placebo for Ergoloid mesylates, Matching placebo for 5-Hydroxytryptophan
Elizabeth Berry-Kravis, FRAXA Research Foundation, Purposeful IKE
Fragile X Syndrome
01/23
01/23
REVEAL, NCT05606614: Safety and Efficacy of TSHA-102 in Adolescent and Adult Females with Rett Syndrome ( Adult Study)

Recruiting
1/2
18
Canada, US
TSHA-102
Taysha Gene Therapies, Inc.
Rett Syndrome
01/25
01/32
NCT06152237: Safety and Efficacy of TSHA-102 in Pediatric Females with Rett Syndrome (REVEAL Pediatric Study)

Recruiting
1/2
20
Europe, Canada, US
TSHA-102
Taysha Gene Therapies, Inc.
Rett Syndrome
11/28
11/31
NCT05301361: Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

Enrolling by invitation
1
68
US
Methylphenidate Oral Solution
University of California, Davis, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Intellectual Disability, Fragile X Syndrome, Down Syndrome, Attention Deficit Hyperactivity Disorder
09/25
09/26
OR-ARI-EAP-NPC, NCT04316637: Early Access Program With Arimoclomol in US Patients With NPC

Available
N/A
US
Arimoclomol
ZevraDenmark
Niemann-Pick Disease, Type C
 
 
NCT02461420: Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

Active, not recruiting
N/A
205
US
Boston Children's Hospital, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Phelan-McDermid Syndrome Foundation
Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability
12/25
12/26
NCT04507997: Angelman Syndrome Natural History Study

Recruiting
N/A
300
Canada, US
Boston Children's Hospital, University of California, San Diego, Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM), Food and Drug Administration (FDA), Angelman Syndrome Foundation Canada, Foundation for Angelman Syndrome Therapeutics Canada, Foundation for Angelman Syndrome Therapeutics, Angelman Syndrome Foundation, Inc.
Angelman Syndrome
08/25
08/25
NCT04476862: Cerliponase Alfa Observational Study in the US

Active, not recruiting
N/A
35
US
Cerliponase Alfa, Brineura, Administration Kit
BioMarin Pharmaceutical
Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2
08/30
08/30
Clarke, David
NCT06229483: The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Recruiting
3
102
Canada
TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, TXA, Placebo, Normal saline (0.9% sodium chloride)
Stephen Lownie, Dalhousie University
Brain Tumor, Bleeding
12/27
12/27
NCT02081768: 90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors

Recruiting
3
40
Canada
90yttrium colloid
David Clarke
Cystic Tumors of the Sellar/Parasellar Region
06/31
10/31
NCT06556212: Real-time Feedback in Swimming: Workout Compliance and Swimming Performance Outcomes Using Smart Swim Goggles

Completed
N/A
57
Canada
Real-time feedback using smart swim goggles
Simon Fraser University, Form Athletica Inc.
Effect of Real-time Visual Feedback on Participant Compliance, Motivation, and Performance in Swimming
12/23
12/23
Robinson, Rhea
NCT02670707: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Recruiting
3
124
US
Cytarabine, cytosine arabinoside (ara-C), Vinblastine/prednisone, Velban/Deltasone
Baylor College of Medicine
Langerhans Cell Histiocytosis
01/25
01/29
NCT05489887: Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Recruiting
2
76
Canada, US
Naxitamab, Danyelza, Ceritinib
Giselle Sholler, Y-mAbs
High-risk Neuroblastoma
09/26
09/33
NMTT, NCT02679144: Neuroblastoma Maintenance Therapy Trial

Recruiting
2
441
Canada, US
Difluoromethylornithine (DFMO), eflornithine
Giselle Sholler, Beat NB Cancer Foundation, Team Parker for Life
Neuroblastoma
02/28
02/33
NCT04696029: DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Recruiting
2
118
US
Difluoromethylornithine, Eflornithine, DFMO
Giselle Sholler
Medulloblastoma
03/28
03/29
NCT04301843: Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

Recruiting
2
131
Canada, US
Eflornithine, DFMO, difluoromethylornithine
Giselle Sholler, K C Pharmaceuticals Inc., Beat NB Cancer Foundation, Team Parker for Life
Neuroblastoma
10/28
10/33
PEDS-PLAN, NCT02559778: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Recruiting
2
500
Canada, US
Ceritinib, Zykadia, dasatinib, Sprycel, sorafenib, Nexavar, vorinostat, ZOLINZA, DFMO, Eflornithine, α-difluoromethylornithine
Giselle Sholler, Dell, Inc., Beat NB Cancer Foundation, K C Pharmaceuticals Inc., Team Parker for Life
Neuroblastoma
09/30
09/35
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Recruiting
N/A
1000
US
Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®
Pfizer, Pfizer
Sickle Cell Disease
01/30
01/30
NCT04715178: Beat Childhood Cancer Specimen Banking and Data Registry

Recruiting
N/A
500
US
No intervention- registry only
Giselle Sholler
Pediatric Cancer
01/31
01/32
ATHN Transcends, NCT04398628: A Natural History Study of Non-Neoplastic Hematologic Disorders

Recruiting
N/A
3000
US
American Thrombosis and Hemostasis Network, Pfizer, Hemophilia of Georgia, Inc., Genentech, Inc., Hemab Therapeutics, CSL Behring, Sanofi, Novo Nordisk A/S
Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder, Hemophilia, Thrombosis, Von Willebrand Diseases, Thrombophilia, Rare Bleeding Disorder, Platelet Disorder, Factor IX Deficiency, Factor VIII Deficiency, Thalassemia, Sickle Cell Disease
06/35
12/35
Pont, Stephen
NCT02121132: Pediatric Obesity Weight Evaluation Registry (POWER) Study

Completed
N/A
4276
US
Children's Hospital Medical Center, Cincinnati, Helen DeVos Children's Hospital, Mayo Clinic, Duke University, National Association of Children's Hospitals and Related Institutions (NACHRI), Milton S. Hershey Medical Center, University of New Mexico, University of Illinois College of Medicine at Peoria, Children's Hospital Los Angeles, Connecticut Children's Medical Center, The Children's Hospital of San Antonio, Ann & Robert H Lurie Children's Hospital of Chicago, Children's Mercy Hospital Kansas City, Arkansas Children's Hospital Research Institute, Florida Hospital for Children, UCSF Benioff Children's Hospital Oakland, University of Oklahoma, MaineHealth, Seattle Children's Hospital, Eastern Maine Medical Center, University of Florida, University of California, Los Angeles, Gramercy Pediatrics, St. Louis Children's Hospital, Dartmouth-Hitchcock Medical Center, University of Alabama at Birmingham, University of Tulsa, Northern Arizona Healthcare, University of Kentucky, Arnold Palmer Hospital for Children, The Cleveland Clinic
Overweight, Obesity
06/24
06/24
Varshney, Pooja
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
Hedequist, Daniel
NCT04730531: Postoperative Pain Control Using Local Wound Infiltration in Adolescent Idiopathic Surgery

Recruiting
N/A
100
US
Local infiltration with 0.25% bupivacaine and epinephrine, Placebo of equal volume injectable saline
Boston Children's Hospital
Postoperative Pain, Spinal Fusion
12/23
12/24
NCT06471348: Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine

Not yet recruiting
N/A
128
US
Bupivacaine liposome injectable suspension, EXPAREL, Bupivacaine Hydrochloride and Epinephrine Injection, Sensorcaine-MPF with Epinephrine 1:200,000
Boston Children's Hospital
Post Operative Pain, Spinal Fusion
08/26
08/28
SPARTAN, NCT05071144: Spine Procedures Assisted With RoboTics And Navigation

Recruiting
N/A
600
US
Boston Children's Hospital, Pediatric Orthopaedic Society of North America, Medtronic, Children's Hospital Colorado, Hospital for Special Surgery, New York, Children's Healthcare of Atlanta, Rainbow Babies and Children's Hospital, Dell Children's Medical Center of Central Texas, Cedars-Sinai Medical Center, Medical University of South Carolina Shawn Jenkins Children's Hospital, St. Louis Children's Hospital
Spine Deformity, Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis, Spondylolisthesis, Congenital Scoliosis, Neuromuscular Scoliosis
12/30
12/31
Julich, Kristina
OR-ARI-EAP-NPC, NCT04316637: Early Access Program With Arimoclomol in US Patients With NPC

Available
N/A
US
Arimoclomol
ZevraDenmark
Niemann-Pick Disease, Type C
 
 
Koch, Kendra
OR-ARI-EAP-NPC, NCT04316637: Early Access Program With Arimoclomol in US Patients With NPC

Available
N/A
US
Arimoclomol
ZevraDenmark
Niemann-Pick Disease, Type C
 
 
Harrod, Virgina
NCT02670707: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Recruiting
3
124
US
Cytarabine, cytosine arabinoside (ara-C), Vinblastine/prednisone, Velban/Deltasone
Baylor College of Medicine
Langerhans Cell Histiocytosis
01/25
01/29
Albert, Orsi
OR-ARI-EAP-NPC, NCT04316637: Early Access Program With Arimoclomol in US Patients With NPC

Available
N/A
US
Arimoclomol
ZevraDenmark
Niemann-Pick Disease, Type C
 
 
Nadasdy, Zoltan
NCT05123469: Clinical Validation of zEEG, a Wireless EEG Recording System for Pediatric and Adult Patients With Epilepsy

Not yet recruiting
N/A
30
US
Electroencephalography
University of Texas at Austin
Epilepsy, EEG With Periodic Abnormalities, EEG With Abnormally Slow Frequencies, EEG; Paroxysms, Occipital, Epilepsy of Childhood, EEG; Spikes, Centrotemporal, Epilepsy of Childhood
12/22
03/23
Modur, Pradeep
NCT05123469: Clinical Validation of zEEG, a Wireless EEG Recording System for Pediatric and Adult Patients With Epilepsy

Not yet recruiting
N/A
30
US
Electroencephalography
University of Texas at Austin
Epilepsy, EEG With Periodic Abnormalities, EEG With Abnormally Slow Frequencies, EEG; Paroxysms, Occipital, Epilepsy of Childhood, EEG; Spikes, Centrotemporal, Epilepsy of Childhood
12/22
03/23
Louis, Reggie I
NCT05123469: Clinical Validation of zEEG, a Wireless EEG Recording System for Pediatric and Adult Patients With Epilepsy

Not yet recruiting
N/A
30
US
Electroencephalography
University of Texas at Austin
Epilepsy, EEG With Periodic Abnormalities, EEG With Abnormally Slow Frequencies, EEG; Paroxysms, Occipital, Epilepsy of Childhood, EEG; Spikes, Centrotemporal, Epilepsy of Childhood
12/22
03/23
Kaufman, Brian
SFSS, NCT05287035: Spinal Fusions Steroid Study

Enrolling by invitation
1
70
US
Dexamethasone injection, Saline injection
University of Texas at Austin
Spinal Fusion
01/25
07/25
SPARTAN, NCT05071144: Spine Procedures Assisted With RoboTics And Navigation

Recruiting
N/A
600
US
Boston Children's Hospital, Pediatric Orthopaedic Society of North America, Medtronic, Children's Hospital Colorado, Hospital for Special Surgery, New York, Children's Healthcare of Atlanta, Rainbow Babies and Children's Hospital, Dell Children's Medical Center of Central Texas, Cedars-Sinai Medical Center, Medical University of South Carolina Shawn Jenkins Children's Hospital, St. Louis Children's Hospital
Spine Deformity, Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis, Spondylolisthesis, Congenital Scoliosis, Neuromuscular Scoliosis
12/30
12/31
Orthopedics, Central Texas Pediatric
SFSS, NCT05287035: Spinal Fusions Steroid Study

Enrolling by invitation
1
70
US
Dexamethasone injection, Saline injection
University of Texas at Austin
Spinal Fusion
01/25
07/25
Gottlieb, Erin
NasoVISI, NCT05433155: Nasotracheal Intubation With VL vs DL in Infants Trial

Recruiting
N/A
1400
US
Nasotracheal intubation
Children's Hospital of Philadelphia, Children's Hospital Colorado, Seattle Children's Hospital, Baylor College of Medicine, Children's Medical Center Dallas, Dell Children's Medical Center of Central Texas, Children's National Research Institute, Vanderbilt University Medical Center
Intubation Complication, Intubation; Difficult or Failed, Hypoxia, Hypoxemia, Anesthesia Intubation Complication, Pediatric HD
12/24
12/25
Jacobson-Kelly, Amanda
NCT02670707: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Recruiting
3
124
US
Cytarabine, cytosine arabinoside (ara-C), Vinblastine/prednisone, Velban/Deltasone
Baylor College of Medicine
Langerhans Cell Histiocytosis
01/25
01/29
Ross, Kirsten
SPARTAN, NCT05071144: Spine Procedures Assisted With RoboTics And Navigation

Recruiting
N/A
600
US
Boston Children's Hospital, Pediatric Orthopaedic Society of North America, Medtronic, Children's Hospital Colorado, Hospital for Special Surgery, New York, Children's Healthcare of Atlanta, Rainbow Babies and Children's Hospital, Dell Children's Medical Center of Central Texas, Cedars-Sinai Medical Center, Medical University of South Carolina Shawn Jenkins Children's Hospital, St. Louis Children's Hospital
Spine Deformity, Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis, Spondylolisthesis, Congenital Scoliosis, Neuromuscular Scoliosis
12/30
12/31

Download Options